...
首页> 外文期刊>Clinical and experimental pharmacology & physiology >Diaphragm muscle strip preparation for evaluation of gene therapies in mdx micE.
【24h】

Diaphragm muscle strip preparation for evaluation of gene therapies in mdx micE.

机译:膜肌条制备,用于评估mdx micE中的基因治疗。

获取原文
获取原文并翻译 | 示例

摘要

1. Duchenne muscular dystrophy (DMD), a severe muscle wasting disease of young boys with an incidence of one in every 3000, results from a mutation in the gene that encodes dystrophin. The absence of dystrophin expression in skeletal muscles and heart results in the degeneration of muscle fibres and, consequently, severe muscle weakness and wasting. The mdx mouse discovered in 1984, with some adjustments for differences, has proven to be an invaluable model for scientific investigations of dystrophy. 2. The development of the diaphagm strip preparation provided an ideal experimental model for investigations of skeletal muscle impairments in structure and function induced by interactions of disease- and age-related factors. Unlike the limb muscles of the mdx mouse, which show adaptive changes in structure and function, the diaphragm strip preparation reflects accurately the deterioration in muscle structure and function observed in boys with DMD. 3. The advent of sophisticated servo motors and force transducers interfaced with state-of-the-art software packages to drive complex experimental designs during the 1990s greatly enhanced the capability of the mdx mouse and the diaphragm strip preparation to evaluate more accurately the impact of the disease on the structure-function relationships throughout the life span of the mouse. 4. Finally, during the 1990s and through the early years of the 21st century, many promising, sophisticated genetic techniques have been designed to ameliorate the devastating impact of muscular dystrophy on the structure and function of skeletal muscles. During this period of rapid development of promising genetic therapies, the combination of the mdx mouse and the diaphragm strip preparation has provided an ideal model for the evaluation of the success, or failure, of these genetic techniques to improve dystrophic muscle structure, function or both. With the 2 year life span of the mdx mouse, the impact of age-related effects can be studied in this model.
机译:1. Duchenne肌营养不良症(DMD)是男童的一种严重的肌肉萎缩性疾病,每3000人中就有1例是由编码肌营养不良蛋白的基因突变引起的。骨骼肌和心脏中缺乏肌营养不良蛋白表达会导致肌纤维变性,并因此导致严重的肌肉无力和消瘦。 1984年发现的mdx鼠标经过一些调整以适应差异,已被证明是营养不良症科学研究的宝贵模型。 2.膜片制剂的开发为研究疾病和年龄相关因素相互作用引起的骨骼肌结构和功能损伤提供了理想的实验模型。与mdx小鼠的四肢肌肉不同,后者的结构和功能会发生适应性变化,隔膜条的准备可准确反映出DMD男孩中观察到的肌肉结构和功能的下降。 3.在1990年代,先进的伺服电机和力传感器与最先进的软件包相结合以驱动复杂的实验设计的问世,大大增强了mdx鼠标和隔膜准备工作的能力,从而可以更准确地评估传感器的影响。该疾病在小鼠的整个生命周期中都与结构-功能关系有关。 4.最后,在1990年代和21世纪初,人们设计了许多有前途的,先进的遗传技术来减轻肌肉营养不良对骨骼肌结构和功能的毁灭性影响。在有前途的遗传疗法迅速发展的这一时期,mdx小鼠和the肌条制剂的结合为评估改善营养不良性肌肉结构,功能或两者的遗传技术的成功或失败提供了理想的模型。 。在mdx鼠标的2年寿命中,可以在此模型中研究与年龄相关的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号